安心颗粒对心肌梗死大鼠血清NO、NOS含量及血管新生影响的实验的分析.pdf

3．1各组大鼠心肌梗死面积的组间比较···························22 3．2各组大鼠血清NO及NOS含量的组间比较····················23 的组间比较··················································24 第三部分讨论·············································26 1．MI模型制备过程的常见问题与关键要点·······················26 2．NO及NOS在缺血性心肌病中的作用··························27 3．冠脉侧枝循环以及血管生成··································29 3．1冠状动脉侧枝循环·········································30 3．2血管生成·················································31 4．安心颗粒的研究基础········································32 4．1安心颗粒的立法依据·······································32 4．2安心颗粒的组方原则···········。···························34 4．3安心颗粒各组成药物对血清NO及NOS影响的实验研究········34 4．4安心颗粒的前期研究·······················-···············35 4．5安心颗粒促血管新生的机制·································36 5存在的问题与展望····················。·····················37 结幸{≥····················································39 参考文献····················································40 附l蛰····················································47 综 述····················································50 蜀【 谢····················································51 攻读学位期间发表的学术论文目录·····························59 作者声明···················，································60 个人简历···················································61 2 中英文缩略 词汇 表 英文缩写 英文全称 中文名称 AS Atherosclerosis 动脉粥样硬化 AXG Anxin 安心颗粒 granules CHD heartdisease 冠状动脉性心脏病 Coromary HDL．C Highdensitylipoprotein 高密度脂蛋白胆固醇 cholester01 MI infarction 心肌梗死 Myocardial NO Nitricoxide 一氧化氮 oxide NOS Nitric synthase